Marwan Emara

1.1k total citations
41 papers, 856 citations indexed

About

Marwan Emara is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marwan Emara has authored 41 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cancer Research, 14 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marwan Emara's work include Cancer, Hypoxia, and Metabolism (8 papers), Neonatal Respiratory Health Research (8 papers) and Hemoglobin structure and function (6 papers). Marwan Emara is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Neonatal Respiratory Health Research (8 papers) and Hemoglobin structure and function (6 papers). Marwan Emara collaborates with scholars based in Canada, Egypt and United States. Marwan Emara's co-authors include Marwa E. Elsherbiny, Joan Allalunis‐Turner, Mohamed H. Ali, A. Robert Turner, Po‐Yin Cheung, Roseline Godbout, David L. Bigam, Mahmoud M. Khattab, Hala F. Zaki and Noha F. Abdelkader and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Archives of Biochemistry and Biophysics.

In The Last Decade

Marwan Emara

39 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marwan Emara Canada 17 401 157 133 117 92 41 856
Haopeng Yang China 22 631 1.6× 109 0.7× 60 0.5× 111 0.9× 37 0.4× 41 1.3k
Cécile Cottet‐Rousselle France 18 684 1.7× 64 0.4× 89 0.7× 233 2.0× 45 0.5× 36 1.2k
Patricia Santofimia‐Castaño Spain 22 764 1.9× 180 1.1× 89 0.7× 83 0.7× 27 0.3× 55 1.3k
Douglas Ganini United States 16 513 1.3× 119 0.8× 97 0.7× 140 1.2× 46 0.5× 27 996
Anna Barańczyk‐Kuźma Poland 17 436 1.1× 114 0.7× 56 0.4× 129 1.1× 71 0.8× 76 974
Gabriella Simbula Italy 19 705 1.8× 154 1.0× 79 0.6× 151 1.3× 40 0.4× 28 1.5k
Eva-Anne Subileau Austria 5 562 1.4× 129 0.8× 92 0.7× 124 1.1× 172 1.9× 6 1.5k
Yoshiaki Sugawara Japan 16 315 0.8× 163 1.0× 276 2.1× 115 1.0× 83 0.9× 44 906
Daqing Sun China 17 463 1.2× 79 0.5× 52 0.4× 143 1.2× 33 0.4× 62 1.4k
Hyun Ji Kim South Korea 18 424 1.1× 135 0.9× 104 0.8× 88 0.8× 95 1.0× 66 1.1k

Countries citing papers authored by Marwan Emara

Since Specialization
Citations

This map shows the geographic impact of Marwan Emara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marwan Emara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marwan Emara more than expected).

Fields of papers citing papers by Marwan Emara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marwan Emara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marwan Emara. The network helps show where Marwan Emara may publish in the future.

Co-authorship network of co-authors of Marwan Emara

This figure shows the co-authorship network connecting the top 25 collaborators of Marwan Emara. A scholar is included among the top collaborators of Marwan Emara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marwan Emara. Marwan Emara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ragheb, Mohamed A., et al.. (2025). Synthesis, cytotoxic evaluation, and binding studies of novel sulphamethoxazole-based cyanoacrylamides as potential antitumor agents. Results in Chemistry. 14. 102119–102119. 3 indexed citations
3.
Barakat, Assem, Mohd Sajid Ali, Muhanna K. Al‐Muhanna, et al.. (2025). Design, synthesis, and anticancer evaluation of spirooxindole–1,2,3-triazole hybrids as potent VEGFR-2 inhibitors. Bioorganic Chemistry. 167. 109278–109278.
4.
Ragheb, Mohamed A., et al.. (2024). Novel Bis(2‐cyanoacrylamide) Linked to Sulphamethoxazole: Synthesis, DNA Interaction, Anticancer, ADMET, Molecular Docking, and DFT Studies. Chemistry & Biodiversity. 21(4). e202301341–e202301341. 12 indexed citations
5.
Elkholi, Islam E., Marwa E. Elsherbiny, & Marwan Emara. (2022). Myoglobin: From physiological roles to potential implications in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1877(3). 188706–188706. 21 indexed citations
6.
Sabet, Salwa, et al.. (2022). The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cells. Molecular Biology Reports. 49(12). 11775–11793. 15 indexed citations
7.
Elsherbiny, Marwa E., et al.. (2021). Expression of Myoglobin in Normal and Cancer Brain Tissues: Correlation With Hypoxia Markers. Frontiers in Oncology. 11. 590771–590771. 7 indexed citations
8.
Hefnawy, Amr, et al.. (2020). Dual-Ligand Functionalized Core-Shell Chitosan-Based Nanocarrier for Hepatocellular Carcinoma-Targeted Drug Delivery. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Hefnawy, Amr, et al.. (2020). <p>Dual-Ligand Functionalized Core-Shell Chitosan-Based Nanocarrier for Hepatocellular Carcinoma-Targeted Drug Delivery</p>. International Journal of Nanomedicine. Volume 15. 821–837. 50 indexed citations
10.
Kamel, Ahmed S., Noha F. Abdelkader, Sahar S. Abd El‐Rahman, et al.. (2018). Stimulation of ACE2/ANG(1–7)/Mas Axis by Diminazene Ameliorates Alzheimer’s Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway. Molecular Neurobiology. 55(10). 8188–8202. 92 indexed citations
11.
Emara, Marwan & Joan Allalunis‐Turner. (2014). Effect of hypoxia on angiogenesis related factors in glioblastoma cells. Oncology Reports. 31(4). 1947–1953. 15 indexed citations
12.
Emara, Marwan, A. Robert Turner, & Joan Allalunis‐Turner. (2013). Adult, embryonic and fetal hemoglobin are expressed in human glioblastoma cells. International Journal of Oncology. 44(2). 514–520. 16 indexed citations
13.
Emara, Marwan, A. Robert Turner, & Joan Allalunis‐Turner. (2013). Hypoxia differentially upregulates the expression of embryonic, fetal and adult hemoglobin in human glioblastoma cells. International Journal of Oncology. 44(3). 950–958. 21 indexed citations
14.
Emara, Marwan, Po‐Yin Cheung, Krzysztof Grabowski, Grzegorz Sawicki, & Mieczysław Woźniak. (2009). Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers. Clinical Chemistry and Laboratory Medicine (CCLM). 47(8). 993–1000. 28 indexed citations
15.
Bigam, David L., Marwan Emara, Graham W. Slack, et al.. (2009). Effects of N-Acetylcysteine on Intestinal Reoxygenation Injury in Hypoxic Newborn Piglets Resuscitated with 100% Oxygen. Neonatology. 96(3). 162–170. 4 indexed citations
16.
Emara, Marwan, et al.. (2008). Expression and hypoxic up‐regulation of neuroglobin in human glioblastoma cells. Molecular Oncology. 3(1). 45–53. 34 indexed citations
17.
Jantzie, Lauren L., et al.. (2008). Persistent neurochemical changes in neonatal piglets after hypoxia–ischemia and resuscitation with 100%, 21% or 18% oxygen. Resuscitation. 77(1). 111–120. 18 indexed citations
18.
Emara, Marwan, et al.. (2007). Expression of angiostatin and its related factors in the plasma of newborn pigs with hypoxia and reoxygenation. Archives of Biochemistry and Biophysics. 466(1). 136–144. 3 indexed citations
19.
Emara, Marwan, et al.. (2007). TEMPORAL PLATELET AGGREGATORY FUNCTION IN HYPOXIC NEWBORN PIGLETS REOXYGENATED WITH 18%, 21%, AND 100% OXYGEN. Shock. 27(4). 448–454. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026